Insights from the 2022 R&D Innovation Survey

In this playbook, we share insights from 33 biopharma executives who reported their experience using these bellwether approaches for the 2022 R&D Innovation Survey conducted by Health Advances and Parexel Biotech. This innovation snapshot shows biotechs adopting new approaches and encountering a variety of roadblocks, but pushing forward to expand their use and deliver faster, more efficient development.

Considered as a whole, findings from the December 2022 R&D Innovation Survey lead us to three top-line insights:

  1. Regulatory and commercial strategies must be considered earlier.
  2. Adaptive designs, ECAs and DCTs are growing in importance.
  3. Biopharma must pursue new ways to increase diversity in clinical trials.

Open PDF

Return to Insights Center

Related Insights

Podcast

Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials

Jun 28, 2024

Podcast

Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Master Protocol Trials: What Are the Elements of Success?

Dec 1, 2021

Blog

Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development

Mar 12, 2024

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Article

4 Insights on decentralized trials for biotechs

Jul 1, 2021

Podcast

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

May 28, 2024

Video

Part 1: Practically Speaking: Driving Clinical Transformation

Feb 9, 2022

Article

Three strategies for articulating a coherent product value story

Dec 18, 2021

Related Insights

Podcast

Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials

Jun 28, 2024

Podcast

Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Master Protocol Trials: What Are the Elements of Success?

Dec 1, 2021

Blog

Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development

Mar 12, 2024

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Show more